News

Press Center


10.10.2017
Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.
More
Topics Petrovax Pharm 
11.08.2017
MMC
Norilsk Nickel was rated 63 on the American magazine Forbes’ list of the world’s
100 most innovative companies.
More
Topics Norilsk Nickel 19.07.2017
The Report discloses the underlying principles and methods, as well as outcomes and outputs in sustainable development.
More
Topics Norilsk Nickel 05.07.2017
Norilsk Nickel with USD 22.36mn ranked first in the Top-15 Russian companies by the value of their intellectual capital. The rating was compiled by the Russian division of the international audit and consulting group Baker Tilly.
More
Topics Norilsk Nickel